Showing results (461-470 of 572) with videos related to
Sort By:
Pageof 58
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2020
Effects of Canagliflozin in Patients with Baseline eGFR 2: Subgroup Analysis of the Randomized CREDENCE TrialGeorge Bakris, Megumi Oshima, Kenneth W Mahaffey, et al.Kidney International Supplements|April 15, 2024
Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)Viviane Calice-Silva, Javier A Neyra, Alejandro Ferreiro Fuentes, et al.CJC Open|April 12, 2021
Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding FactorsTerry Lee, Alessandro Cau, Matthew Pellan Cheng, et al.Lancet (London, England)|June 4, 2026
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trialHiddo J L Heerspink, Meg J Jardine, Donald E Kohan, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 2016
A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized TrialRichard A Brigandi, Brendan Johnson, Coreen Oei, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2008
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysisMichel Chonchol, Francesco Locatelli, Hanna E Abboud, et al.American Journal of Nephrology|December 19, 2017
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline CharacteristicsMeg J Jardine, Kenneth W Mahaffey, Bruce Neal, et al.The Lancet. Global Health|February 16, 2024
An update on the global disparities in kidney disease burden and care across world countries and regionsAminu K Bello, Ikechi G Okpechi, Adeera Levin, et al.Kidney International Supplements|May 13, 2021
International Society of Nephrology Global Kidney Health Atlas: structures, organization and services for the management of kidney failure in North and East AsiaLuxia Zhang, Jinwei Wang, Chih-Wei Yang, et al.Journal of the American Heart Association|August 5, 2022
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE TrialJing-Wei Li, Clare Arnott, Hiddo J L Heerspink, et al.Pageof 58